Bone disorders in chronic liver diseases
- PMID: 21104208
- DOI: 10.1007/s11894-010-0166-4
Bone disorders in chronic liver diseases
Abstract
Bone disease is a major complication of chronic liver disease. Osteomalacia is quite uncommon despite low vitamin D levels in the majority of patients with cirrhosis. In contrast, osteoporosis is quite common, occurring in up to 50% of patients. Osteoporosis can result in spontaneous or low-impact fractures in patients with chronic liver diseases, adversely affecting morbidity, quality of life, and survival. The general biology of osteoporosis, including its pathogenesis, diagnostic tools, and rationale for treatment, have been determined largely empirically from studies of postmenopausal women with osteoporosis. Treatment regimens with modification of risk factors, use of vitamin D, and supplementation with calcium and bisphosphonates have been shown to be effective in select groups of patients with chronic liver diseases.
Similar articles
-
Parkinson disease and metabolic bone disorders: a common connection that needs more attention.Endocr Pract. 2012 Jul-Aug;18(4):591-4. doi: 10.4158/EP12020.CO. Endocr Pract. 2012. PMID: 22548948 Review. No abstract available.
-
RISK FACTORS ASSOCIATED WITH FRACTURE OF THE LUMBOSACRAL SPINE AND ITS COMPROMISE IN THE QUALITY OF LIFE OF CIRRHOTICS.Arq Gastroenterol. 2022 Jan-Mar;59(1):9-15. doi: 10.1590/S0004-2803.202200001-03. Arq Gastroenterol. 2022. PMID: 35442344
-
Osteodystrophy in chronic liver diseases.Intern Emerg Med. 2013 Aug;8(5):377-88. doi: 10.1007/s11739-012-0753-5. Epub 2012 Jan 13. Intern Emerg Med. 2013. PMID: 22241574 Review.
-
Bone disorders in cholestatic liver diseases.Forum (Genova). 1998 Jan-Mar;8(1):28-38. Forum (Genova). 1998. PMID: 9514992 Review.
-
Bone Health in Patients With Liver Diseases.J Clin Densitom. 2020 Apr-Jun;23(2):212-222. doi: 10.1016/j.jocd.2019.01.004. Epub 2019 Jan 18. J Clin Densitom. 2020. PMID: 30744928 Review.
Cited by
-
Osteoporosis in liver disease: pathogenesis and management.Ther Adv Endocrinol Metab. 2016 Jun;7(3):128-35. doi: 10.1177/2042018816641351. Epub 2016 Apr 6. Ther Adv Endocrinol Metab. 2016. PMID: 27293541 Free PMC article. Review.
-
oxLDL inhibits differentiation of mesenchymal stem cells into osteoblasts via the CD36 mediated suppression of Wnt signaling pathway.Mol Biol Rep. 2019 Jun;46(3):3487-3496. doi: 10.1007/s11033-019-04735-5. Epub 2019 Mar 7. Mol Biol Rep. 2019. PMID: 30847850
-
Hepatic osteodystrophy: An important matter for consideration in chronic liver disease.World J Hepatol. 2011 Dec 27;3(12):300-7. doi: 10.4254/wjh.v3.i12.300. World J Hepatol. 2011. PMID: 22216370 Free PMC article.
-
Hepatic osteodystrophy.Clin Cases Miner Bone Metab. 2014 Sep;11(3):185-91. Clin Cases Miner Bone Metab. 2014. PMID: 25568651 Free PMC article. Review.
-
Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected Mediterranean subjects.BMC Infect Dis. 2012 Aug 15;12:192. doi: 10.1186/1471-2334-12-192. BMC Infect Dis. 2012. PMID: 22894751 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical